Ipsen S.A.

EPA:IPN.PA

116.8 (EUR) • At close October 17, 2024
Bedrijfsnaam Ipsen S.A.
Symbool IPN.PA
Munteenheid EUR
Prijs 116.8
Beurswaarde 9,652,260,312
Dividendpercentage 0.99%
52-weken bereik 99.7 - 126.7
Industrie Drug Manufacturers—Specialty & Generic
Sector Healthcare
CEO Mr. David Loew
Website https://www.ipsen.com

An error occurred while fetching data.

Over Ipsen S.A.

Ipsen S.A. operates as a biopharmaceutical company worldwide. The company provides drugs in the areas of oncology, neuroscience, gastroenterology, cognitive disorders, and rare diseases. It offers Somatuline for neuroendocrine tumors and acromegaly; Decapeptyl for the treatment of advanced metastatic prostate cancer; Cabometyx for renal cell and second-line hepatocellular carcinoma; Onivyde

Vergelijkbare Aandelen

Odontoprev S.A. logo

Odontoprev S.A.

ODPV3.SA

10.55 BRL

Ryman Healthcare Limited logo

Ryman Healthcare Limited

RYM.NZ

5.43 NZD

bioMérieux S.A. logo

bioMérieux S.A.

BIM.PA

106.6 EUR

Fleury S.A. logo

Fleury S.A.

FLRY3.SA

14.91 BRL

Fisher & Paykel Healthcare Corporation Limited logo

Fisher & Paykel Healthcare Corporation Limited

FPH.NZ

20.7 NZD

Grifols, S.A. logo

Grifols, S.A.

GRF.MC

9.846 EUR

Financière de Tubize SA logo

Financière de Tubize SA

TUB.BR

141 EUR

Laboratorios Farmaceuticos Rovi, S.A. logo

Laboratorios Farmaceuticos Rovi, S.A.

ROVI.MC

76.3 EUR

Qualicorp Consultoria e Corretora de Seguros S.A. logo

Qualicorp Consultoria e Corretora de Seguros S.A.

QUAL3.SA

2.2 BRL

Virbac SA logo

Virbac SA

VIRP.PA

395.5 EUR

Financiële Gegevens

Cijfers zijn in miljoenen (EUR)

Cijfers zijn in miljoenen (EUR)